Clearside Biomedical Inc. (CLSD)
NASDAQ: CLSD
· Real-Time Price · USD
0.50
-0.04 (-7.20%)
At close: Jul 25, 2025, 3:59 PM
Clearside Biomedical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -30.81M | -34.35M | -31.88M | -33.46M | -34.97M | -32.48M | -37.32M | -35.88M | -34.58M | -32.95M | -4.58M | -1.64M | 83K | 376K | -25.45M | -22.99M | -22.65M |
Depreciation & Amortization | 283K | 226K | 167K | 108K | 80K | 67K | 69K | 92K | 114K | 145K | 168K | 173K | 179K | 178K | 177K | 179K | 180K |
Stock-Based Compensation | 4.17M | 4.51M | 4.37M | 4.28M | 4.22M | 4.2M | 4.33M | 4.33M | 4.62M | 4.88M | 4.99M | 5.23M | 5.21M | 5.05M | 4.67M | 4.19M | 3.75M |
Other Working Capital | -255K | -225K | 475K | 551K | 228K | -961K | -2.16M | -814.42K | -1.38M | 10.63M | 5.42M | 5.6M | 3.83M | -6.78M | 658K | -706K | 2.96M |
Other Non-Cash Items | 2.69M | 8.82M | 11.06M | 11.76M | 13.74M | 9.78M | 9.1M | 7.58M | 5.28M | 3.12M | -14.25M | -15.34M | -15.34M | -16.34M | 124K | 124K | 281K |
Deferred Income Tax | n/a | n/a | -419K | -419K | -419K | -419K | n/a | n/a | 1K | 1K | 15.34M | 15.34M | 15.34M | 15.34M | -1.12M | -1.12M | -1.12M |
Change in Working Capital | -597K | -1.68M | -20K | 840K | 799K | 720K | -418K | -667K | -85K | 11.24M | -4.58M | -3.56M | -6.77M | -15.34M | 1.38M | 11K | 3.68M |
Operating Cash Flow | -22.68M | -24.7M | -18.95M | -19.11M | -18.77M | -18.14M | -24.24M | -24.35M | -24.45M | -13.37M | -2.7M | 204K | -1.3M | -10.73M | -20.22M | -19.61M | -15.88M |
Capital Expenditures | -920K | -977K | -653K | -1.04M | -1.72M | -1.78M | -1.75M | -1.46M | -361K | -246K | -155K | n/a | n/a | n/a | -55K | -110K | -110K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -5.9M | -5.9M | -5.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 9.75M | 9.75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -3.52M | -3.73M | -6.04M | -13.54M | -2.53M | -2.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -590K | -638K | -10.06M | -12.06M | -1.72M | -1.78M | -1.75M | -1.46M | -361K | -246K | -155K | n/a | n/a | n/a | -55K | -110K | -110K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | 21K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -539K | 47K | -953K | -916K | -1.26M | -1.25M | -243K | 30.39M | 30.74M | 30.77M | 30.92M | 440K | 469K | 496K | 341K | 280K | -4M |
Financial Cash Flow | 1.54M | 16.44M | 14.1M | 14.4M | 14.43M | 414K | 1.25M | 31.62M | 31.6M | 31.33M | 30.92M | 2.31M | 9.43M | 23.78M | 30.5M | 30.85M | 21.09M |
Net Cash Flow | -21.73M | -8.9M | -14.91M | -16.77M | -6.06M | -19.5M | -24.74M | 5.81M | 6.79M | 17.72M | 28.06M | 2.52M | 8.13M | 13.05M | 10.28M | 11.24M | 5.22M |
Free Cash Flow | -23.6M | -25.68M | -19.6M | -20.16M | -20.49M | -19.91M | -25.98M | -25.81M | -24.81M | -13.61M | -2.86M | 204K | -1.3M | -10.73M | -20.28M | -19.72M | -15.99M |